Human PCSK9 ELISA Kit |
EK5497 |
SAB |
96 tests |
EUR 599 |
|
Human IgG antibody Laboratories manufactures the merck pcsk9 elisa reagents distributed by Genprice. The Merck Pcsk9 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact pcsk9 elisa. Other Merck products are available in stock. Specificity: Merck Category: Pcsk9 Group: Elisa
Human True insulin ELISA Kit |
MyBiosource |
48-Strip-Wells-(Sandwich) |
EUR 485 |
Human True insulin ELISA Kit |
MyBiosource |
5x96-Strip-Wells-(Competitive) |
EUR 3020 |
Human True insulin ELISA Kit |
MyBiosource |
96-Strip-Wells-(Competitive) |
EUR 690 |
Human True insulin ELISA Kit |
MyBiosource |
96-Strip-Wells-(Sandwich) |
EUR 690 |
Human True insulin (TI) ELISA Kit |
SAB |
96Т |
EUR 799 |
|
Human True Insulin(TI) ELISA Kit |
Enlibio |
each |
EUR 430 |
Elisa information
Mouse PCSK9 ELISA Kit |
MBS824483-96Tests |
MyBiosource |
96Tests |
EUR 645 |
Human PCSK9 ELISA Kit |
MBS8123874-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2200 |
Human PCSK9 ELISA Kit |
MBS8123874-96Tests |
MyBiosource |
96Tests |
EUR 480 |
Human PCSK9 ELISA Kit |
STA-385 |
Cell Biolabs |
96 assays |
EUR 818.4 |
Description: Proprotein convertase subtilisin kexin 9 (PCSK9), also named neural apoptosis-regulated convertase 1 (NARC-1), is a member of the proteinase K subfamily of subtilisin-related serine endoproteases. PCSK9 has profound effects on plasma low-density lipoprotein (LDL)-cholesterol (LDL-C) levels through its ability to mediate LDL receptor (LDLR) protein degradation, its primary function. Cell Biolabs? Human PCSK9 ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of human PCSK9 in plasma, serum, cell or tissue lysate samples. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. |
Merck SIP Agonist |
MBS130297-100mg |
MyBiosource |
100mg |
EUR 1065 |
Merck SIP Agonist |
MBS130297-500mg |
MyBiosource |
500mg |
EUR 2775 |
Merck SIP Agonist |
MBS386918-100mg |
MyBiosource |
100mg |
EUR 1150 |
Merck SIP Agonist |
MBS386918-10mg |
MyBiosource |
10mg |
EUR 240 |
Merck SIP Agonist |
MBS386918-25mg |
MyBiosource |
25mg |
EUR 465 |
Merck SIP Agonist |
MBS386918-50mg |
MyBiosource |
50mg |
EUR 690 |
Merck SIP Agonist |
MBS386918-5x100mg |
MyBiosource |
5x100mg |
EUR 5175 |
PCSK9 (human) ELISA Kit |
K7265-100 |
Biovision |
each |
EUR 966 |
PCSK9 (mouse) ELISA Kit |
K7266-100 |
Biovision |
each |
EUR 1005.6 |
PCSK9 ELISA Kit (Rat) (OKEH02981) |
OKEH02981 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
Description: Description of target: Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.088 ng/mL |
Pcsk9 ELISA Kit (Rat) (OKBB01192) |
OKBB01192 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
Description: Description of target: PCSK9 is the 9th member of the proprotein convertase family of proteins that activate other proteins.PCSK9 has medical importance because it acts in lipoprotein homeostasis. PCSK9 is ubiquitously expressed in many tissues and cell types. PCSK9 binds to the receptor for low-density lipoprotein particles (LDL), which typically transport 3,000 to 6,000 fat molecules (including cholesterol) per particle, within extracellular fluid. The LDL receptor (LDLR), on liver and other cell membranes, binds and initiates ingestion of LDL-particles from extracellular fluid into cells, thus reducing LDL particle concentrations. ;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |